MORGAN STANLEY PLC/CALL/FRESENIUS/24/0.1/20.12.24 Share Price

Warrant

DE000MB315A6

Market Closed - Börse Stuttgart 11:35:23 28/06/2024 pm IST
0.5 EUR 0.00% Intraday chart for MORGAN STANLEY PLC/CALL/FRESENIUS/24/0.1/20.12.24
Current month-20.63%
1 month-19.35%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
28/24/28 0.5 0.00%
27/24/27 0.5 0.00%
26/24/26 0.5 -3.85%
25/24/25 0.52 -1.89%
24/24/24 0.53 +1.92%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 11:35 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying FRESENIUS SE & CO. KGAA
Issuer Morgan Stanley
WKN MB315A
ISINDE000MB315A6
Date issued 31/01/2023
Strike 24
Maturity 20/12/2024 (175 Days)
Parity 10 : 1
Emission price 0.73
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.92
Lowest since issue 0.29
Delta0.8x
Omega 4.369
Premium4.38x
Gearing5.47x
Moneyness 1.162
Difference Strike -3.88
Difference Strike %-16.17%
Spread 0.02
Spread %3.85%
Theoretical value 0.5100
Implied Volatility 33.35 %
Total Loss Probability 27.15 %
Intrinsic value 0.3880
Present value 0.1220
Break even 29.10 €
Theta-0x
Vega0.01x
Rho0.01x

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (64.3%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (35.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (72.4%), North America (12.3%), Asia/Pacific (7.3%), Latin America (6.4%) and Africa (1.6%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
27.88 EUR
Average target price
37.26 EUR
Spread / Average Target
+33.63%
Consensus